Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

01.04.2024

1 Arch Virol
1 Biochem Biophys Res Commun
1 BMC Pediatr
2 BMJ
1 J Virol
4 JAMA
3 Lancet
1 MMWR Morb Mortal Wkly Rep
1 PLoS Comput Biol
22 PLoS One
4 Vaccine
2 Virus Res


    Arch Virol

  1. LI X, Ding G, Li S, Liu C, et al
    Proteomic characteristics of the treatment trajectory of patients with COVID-19.
    Arch Virol. 2024;169:84.
    >> Share


    Biochem Biophys Res Commun

  2. HE K, Ye Y, Liu S, Yuan P, et al
    Polylevodopa nanoplatform for lateral flow immunochromatography assay of SARS-CoV-2 and influenza A virus.
    Biochem Biophys Res Commun. 2024;709:149821.
    >> Share


    BMC Pediatr

  3. TANG CM, Kuo CY, Yen CW, Lin JJ, et al
    Predicting factors for acute encephalopathy in febrile seizure children with SARS-CoV-2 omicron variant: a retrospective study.
    BMC Pediatr. 2024;24:211.
    >> Share


    BMJ

  4. MAHASE E
    Covid-19: Pfizer vaccine to be available privately at pharmacy chain Boots from April.
    BMJ. 2024;384:q762.
    >> Share

  5. SHEPHERD A
    Covid remembered in NHS portraits.
    BMJ. 2024;384:q741.
    >> Share


    J Virol

  6. BRICKER TL, Joshi A, Soudani N, Scheaffer SM, et al
    Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.
    J Virol. 2024 Feb 2:e0120623. doi: 10.1128/jvi.01206.
    >> Share


    JAMA

  7. HARRIS E
    Better Outcomes When Kidney Damage Is From COVID-19.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1574.
    >> Share

  8. HARRIS E
    HPV Vaccination Rates Stagnated During COVID-19 Pandemic.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1569.
    >> Share

  9. HARRIS E
    CDC Tracking BA.2.87.1, New Omicron Subvariant With Potential to Evade Immunity.
    JAMA. 2024;331:907.
    >> Share

  10. ANDERSSON NW, Thiesson EM, Hviid A
    Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
    JAMA. 2024 Feb 26:e241036. doi: 10.1001/jama.2024.1036.
    >> Share


    Lancet

  11. PARHIZ H, Atochina-Vasserman EN, Weissman D
    mRNA-based therapeutics: looking beyond COVID-19 vaccines.
    Lancet. 2024 Mar 7:S0140-6736(23)02444-3. doi: 10.1016/S0140-6736(23)02444.
    >> Share

  12. SHAWE-TAYLOR M, Greenwood D, Hobbs A, Dowgier G, et al
    Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
    Lancet. 2024 Mar 11:S0140-6736(24)00316-7. doi: 10.1016/S0140-6736(24)00316.
    >> Share

  13. SZANYI J, Howe S, Blakely T
    The importance of reporting accurate estimates of long COVID prevalence.
    Lancet. 2024;403:1136-1137.
    >> Share


    MMWR Morb Mortal Wkly Rep

  14. WILLIAMS SL, Smith DJ, Benedict K, Ahlers JR, et al
    Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis During the COVID-19 Pandemic - United States, 2019-2021.
    MMWR Morb Mortal Wkly Rep. 2024;73:239-244.
    >> Share


    PLoS Comput Biol

  15. HASSE T, Mantei E, Shahoei R, Pawnikar S, et al
    Mechanistic insights into ligand dissociation from the SARS-CoV-2 spike glycoprotein.
    PLoS Comput Biol. 2024;20:e1011955.
    >> Share


    PLoS One

  16. SCHUMACHER A, Micheli L
    Anticipated scarcity and stockpiling during the COVID-19 pandemic: The role of perceived threat, childhood SES and materialism.
    PLoS One. 2024;19:e0294497.
    >> Share

  17. ABUGATTAS-NUNEZ DEL PRADO J, Quintana Reyes A, Leon J, Blume La Torre J, et al
    Clinical validation of RCSMS: A rapid and sensitive CRISPR-Cas12a test for the molecular detection of SARS-CoV-2 from saliva.
    PLoS One. 2024;19:e0290466.
    >> Share

  18. TIRUNEH GT, Fesseha N, Emaway D, Betemariam W, et al
    Effect of community-based newborn care implementation strategies on access to and effective coverage of possible serious bacterial infection (PSBI) treatment for sick young infants during COVID-19 pandemic.
    PLoS One. 2024;19:e0300880.
    >> Share

  19. AHMAD T, Ibrahim M, Naz O, Abdullah M, et al
    Optimizing immunization services: A Data Envelopment Analysis (DEA) of child immunization facilities in Pakistan.
    PLoS One. 2024;19:e0298308.
    >> Share

  20. GHEIDARI D, Mehrdad M, Bayat M
    Synthesis, molecular docking analysis, molecular dynamic simulation, ADMET, DFT, and drug likeness studies: Novel Indeno[1,2-b]pyrrol-4(1H)-one as SARS-CoV-2 main protease inhibitors.
    PLoS One. 2024;19:e0299301.
    >> Share

  21. WAN PUTEH SE, Aazmi MS, Aziz MN, Kamarudin N', et al
    Cross-sectional study of influenza trends and costs in Malaysia between 2016 and 2018.
    PLoS One. 2024;19:e0301068.
    >> Share

  22. TAILLANDIER P, Chapuis K, Gaudou B, Brugiere A, et al
    COMOKIT v2: A multi-scale approach to modeling and simulating epidemic control policies.
    PLoS One. 2024;19:e0299626.
    >> Share

  23. THIEULENT CJ, Carossino M, Peak L, Wolfson W, et al
    Development and validation of multiplex one-step qPCR/RT-qPCR assays for simultaneous detection of SARS-CoV-2 and pathogens associated with feline respiratory disease complex.
    PLoS One. 2024;19:e0297796.
    >> Share

  24. ZHAO L, Ferraro P, Shorten R
    A smart mask to enforce social contracts based on IOTA Tangle.
    PLoS One. 2024;19:e0292850.
    >> Share

  25. TOWNSLEY H, Gahir J, Russell TW, Greenwood D, et al
    COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.
    PLoS One. 2024;19:e0294897.
    >> Share

  26. ADAMCZYK G
    Pathological buying on the rise? Compensative and compulsive buying in Poland in the pre- and (Post-)pandemic times.
    PLoS One. 2024;19:e0298856.
    >> Share

  27. GUERRERIO AL, Mateja A, MacCarrick G, Fintzi J, et al
    Web-based survey investigating cardiovascular complications in hypermobile Ehlers-Danlos syndrome after COVID-19 infection and vaccination.
    PLoS One. 2024;19:e0298272.
    >> Share

  28. GEORGE JF
    Discovering why people believe disinformation about healthcare.
    PLoS One. 2024;19:e0300497.
    >> Share

  29. ZHOU R, Johnson KE, Rousseau JF, Rathouz PJ, et al
    Comparative effectiveness of dexamethasone in treatment of hospitalized COVID-19 patients in the United States during the first year of the pandemic: Findings from the National COVID Cohort Collaborative (N3C) data repository.
    PLoS One. 2024;19:e0294892.
    >> Share

  30. NAGASAWA S, Hirata Y, Miyamoto S, Ozono S, et al
    Changes in SARS-CoV-2 viral load and titers over time in SARS-CoV-2-infected human corpses.
    PLoS One. 2024;19:e0287068.
    >> Share

  31. DIMNJAKOVIC J, Buble T, Ivanko P, Poljicanin T, et al
    Association of anti-diabetic drugs and covid-19 outcomes in patients with diabetes mellitus type 2 and chronic kidney disease: Nationwide registry analysis.
    PLoS One. 2024;19:e0301056.
    >> Share

  32. KOMORI A, Mori H, Xie W, Valenti S, et al
    Rapid resurgence of syphilis in Japan after the COVID-19 pandemic: A descriptive study.
    PLoS One. 2024;19:e0298288.
    >> Share

  33. RENZI E, Baccolini V, Covelli A, Siena LM, et al
    Keeping university open did not increase the risk of SARS-CoV-2 acquisition: A test negative case-control study among students.
    PLoS One. 2024;19:e0301215.
    >> Share

  34. CANGUSSU LR, Do Nascimento JAS, de Barros IRP, Cavalcanti RL, et al
    Effects of primary health care and socioeconomic aspects on the dispersion of COVID-19 in the Brazilian Northeast: Ecological study of the first pandemic wave.
    PLoS One. 2024;19:e0296837.
    >> Share

  35. BRAY LA, Jervis LL, Janitz AE, Ross L, et al
    Toward trustworthy COVID-19 interventions: Building vaccine trust through community-university partnerships.
    PLoS One. 2024;19:e0300872.
    >> Share

  36. XUE J, Zhou X, Yang J, Niu A, et al
    Comparative study on differential expression analysis methods for single-cell RNA sequencing data with small biological replicates: Based on single-cell transcriptional data of PBMCs from COVID-19 severe patients.
    PLoS One. 2024;19:e0299358.
    >> Share

  37. BLAKE L, Tucker P, Vanderloo LM
    Mothers' perspectives of the barriers and facilitators to reducing young children's screen time during COVID-19: A reddit content analysis.
    PLoS One. 2024;19:e0301089.
    >> Share


    Vaccine

  38. KLUWER B, Gleditsch R, Rydland KM, Mamelund SE, et al
    Higher educational attainment associated with higher confidence in influenza vaccination in Norway.
    Vaccine. 2024 Mar 21:S0264-410X(24)00338-4. doi: 10.1016/j.vaccine.2024.
    >> Share

  39. VOLKMANN AM, Goldin S, McMurren B, Gapare C, et al
    Leveraging seasonal influenza health worker vaccination programmes for COVID-19 vaccine Introduction: A global qualitative analysis.
    Vaccine. 2024 Mar 25:S0264-410X(23)01490-1. doi: 10.1016/j.vaccine.2023.
    >> Share

  40. BIEGUS J, Szenborn L, Zymlinski R, Zakliczynski M, et al
    The early safety profile of simultaneous vaccination against influenza and Respiratory Syncytial Virus (RSV) in patients with high-risk heart failure.
    Vaccine. 2024 Mar 25:S0264-410X(24)00366-9. doi: 10.1016/j.vaccine.2024.
    >> Share

  41. DALEY MF, Reifler LM, Shoup JA, Glanz JM, et al
    Influenza vaccination accuracy among adults: Self-report compared with electronic health record data.
    Vaccine. 2024 Mar 25:S0264-410X(24)00339-6. doi: 10.1016/j.vaccine.2024.
    >> Share


    Virus Res

  42. KUZIKOV M, Reinshagen J, Wycisk K, Corona A, et al
    Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex.
    Virus Res. 2024;343:199356.
    >> Share

  43. GLENET M, Lebreil AL, N'Guyen Y, Meyer I, et al
    Structural impact of a new spike Y170W mutation detected in early emerging SARS-CoV-2 Omicron variants in France.
    Virus Res. 2024;343:199354.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016